1. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2
    Feng Yan Yu et al, 2016, Cancer Biology & Therapy CrossRef
  2. The role of microRNA-26a in human cancer progression and clinical application
    Jing Chen et al, 2016, Tumor Biol. CrossRef
  3. null
    Panagiotis Paliogiannis et al, 2017 CrossRef
  4. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers
    Christian Mayr et al, 2016, BioMed Research International CrossRef
  5. The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer
    Nina Nayara Ferreira Martins et al, 2016, Gastroenterology Research and Practice CrossRef
  6. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
    Pablo Letelier et al, 2016, IJMS CrossRef
  7. A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin
    Laura Arnoldo et al, 2015, Sci Rep CrossRef
  8. The role of microRNAs in gallbladder cancer
    GANGHUA YANG et al, 2016 CrossRef
  9. MicroRNA aberrations: An emerging field for gallbladder cancer management
    Vishal Chandra, 2016, WJG CrossRef
  10. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma
    Ning Wang et al, 2017, Biochimie CrossRef
  11. Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells
    Renata C. Costa de Freitas et al, 2017, Front. Pharmacol. CrossRef
  12. Translational applications of microRNAs in cancer, and therapeutic implications
    Grace T. Kwok et al, 2017, Non-coding RNA Research CrossRef
  13. Advances in biomarkers of biliary tract cancers
    Jun Hu et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  14. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2
    Wenzhong Chen et al, 2017 CrossRef
  15. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression
    Riccardo Sgarra et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  16. The deregulated microRNAome contributes to the cellular response to aneuploidy
    Milena Dürrbaum et al, 2018, BMC Genomics CrossRef
  17. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma
    J B H Mello et al, 2018 CrossRef
  18. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
    Wei Liu et al, 0 CrossRef
  19. Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma
    Qiuli Li et al, 2019, Cancer Biology & Therapy CrossRef
  20. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression
    Maryam Moradi Binabaj et al, 2019, Gene CrossRef
  21. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy
    Zongji Zheng et al, 2016, Sci Rep CrossRef
  22. MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene.
    Hui Qian et al, 2017, Cell Death Discov CrossRef
  23. Molecular Pathogenesis of Gallbladder Cancer: An Update
    Shravan Kumar Mishra et al, 2019, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis CrossRef
  24. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN
    Hongyi Liu et al, 2014, Tumor Biol. CrossRef
  25. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer
    Rongkai Lin et al, 2014, Biomedicine & Pharmacotherapy CrossRef
  26. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy
    Carolina Bizama et al, 2015, Cancer Treatment Reviews CrossRef
  27. Evaluation of miR-27a, miR-181a, and miR-570 Genetic Variants with Gallbladder Cancer Susceptibility and Treatment Outcome in a North Indian Population
    Annapurna Gupta et al, 2015, Mol Diagn Ther CrossRef
  28. MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer
    Baoguo Zhou et al, 2016, Mol. Carcinog. CrossRef
  29. Non-coding RNAs as emerging molecular targets of gallbladder cancer
    Dinesh Singh Tekcham et al, 2016, Gene CrossRef
  30. The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3′UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2
    Yuan Wang et al, 2017, Sci Rep CrossRef
  31. Up-regulated microRNA-33b inhibits epithelial–mesenchymal transition in gallbladder cancer through down-regulating CROCC
    Guohui Xu et al, 2020 CrossRef
  32. High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network
    Riccardo Sgarra et al, 2020, IJMS CrossRef
  33. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2
    Ying Shao et al, 2016, Oncotarget CrossRef
  34. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
    Li-Juan Wang et al, 2015, Oncotarget CrossRef
  35. MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer
    Zheng Li et al, 2015, Oncotarget CrossRef
  36. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Jian Liu et al, 0 CrossRef
  37. Inhibition of microRNA‑939 suppresses the development of human non‑small cell lung cancer via the upregulation of tissue inhibitor of metalloproteinases 2
    Aidong Chen et al, 2018, Mol Med Report CrossRef
  38. The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
    Yuliya Andreevna Veryaskina et al, 2020, Cells CrossRef
  39. miR-26 family and its target genes in tumorigenesis and development.
    Chuangang Li et al, 2021, Crit Rev Oncol Hematol CrossRef
  40. A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma
    Sonam Tulsyan et al, 2020, Seminars in Oncology CrossRef
  41. Research Progress on FOXF2 Gene in Tumors
    勍 陈, 2021, ACM CrossRef
  42. null
    Bela Goyal et al, 2022 CrossRef
  43. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA
    Jun Yan et al, 2021, Mol Med Rep CrossRef
  44. null
    Anurag Mishra et al, 2023 CrossRef
  45. null
    Nivedita Sharma et al, 2023 CrossRef
  46. null
    Pavan Baichan et al, 2023 CrossRef
  47. HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response
    Mehrdad Hashemi et al, 2023, Pharmacological Research CrossRef
  48. The potential role of miRNAs in the pathogenesis of gallbladder cancer - A focus on signaling pathways interplay
    Ahmed S. Doghish et al, 2023, Pathology - Research and Practice CrossRef
  49. miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance
    Reem K. Shahin et al, 2023, Pathology - Research and Practice CrossRef
  50. Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation
    Ming-jie Jiang et al, 2024, Heliyon CrossRef